Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

Clin Transl Med · 2023 · PMC10739156 · PMID 38131168

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The score shows an increasing trend even though not to the point of significance (Figure 2G ).

also in 63,971 other papers

showed a trendno p-value reported

IHC showed a trend of downregulation of CHIL3 in the treated tumour even though not reaching statistical significance ( p = .13) (Figure 7A,B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.